• Login
  • Register
Nairametrics
  • Home
  • Exclusives
    • Recapitalization
      • Access Holdings Offer
      • Fidelity Bank Offer
      • GTCO Offer
      • Zenith Bank Offer
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Nairalytics
  • Economy
    • Business News
    • Budget
    • Public Debt
    • Tax
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Public Offer & Right Issues
      • Stock Market News
    • Fixed Income
    • Funds Management
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Market Views
    • Op-Eds
    • Research Analysis
  • Home
  • Exclusives
    • Recapitalization
      • Access Holdings Offer
      • Fidelity Bank Offer
      • GTCO Offer
      • Zenith Bank Offer
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Nairalytics
  • Economy
    • Business News
    • Budget
    • Public Debt
    • Tax
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Public Offer & Right Issues
      • Stock Market News
    • Fixed Income
    • Funds Management
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Market Views
    • Op-Eds
    • Research Analysis
Nairametrics
Home Sectors

Elon Musk’s ketamine use excluded from OpenAI fraud trial 

Deborah Dan-Awoh by Deborah Dan-Awoh
March 14, 2026
in Sectors, Tech News
X may lose $75m in revenue as advertisers walkout
Share on FacebookShare on TwitterShare on Linkedin

Elon Musk’s past use of the drug ketamine will not be admissible as evidence in his high-stakes legal battle with OpenAI Inc. and Microsoft Corp., a U.S. federal judge ruled, as the Silicon Valley trial over potential fraud inches closer.

At a Friday hearing in Oakland, California, U.S. District Judge Yvonne Gonzalez Rogers clarified the scope of evidence for the case, which will revisit the founding of OpenAI a decade ago, its split with Musk, and Microsoft’s subsequent $13 billion investment in the AI startup.

The trial, set to begin April 28, will focus on whether OpenAI co-founders, including CEO Sam Altman and Greg Brockman, misrepresented their intent to maintain a nonprofit structure when Musk contributed $38 million in seed funding.

MoreStories

Meet Apple Inc.’s new CEO, John Ternus, to lead $4 trillion tech giant 

Meet Apple Inc.’s new CEO, John Ternus, to lead $4 trillion tech giant 

April 21, 2026
Oil price bearish as Iranian supply worries investors

Analysts: Iran war shows Nigeria’s response toolkits not adequate  

April 21, 2026

What they are saying 

Musk is seeking up to $134 billion in damages, a figure that would rank among the largest verdicts in U.S. history if awarded.

OpenAI and Microsoft have denied the allegations, and the judge expressed skepticism of the damages calculations presented by Musk’s expert witness, financial economist C.

Paul Wazzan, who argued Musk could be entitled to between $79 billion and $134 billion based on OpenAI’s current valuation. Gonzalez Rogers noted that Wazzan’s methodology was “not particularly persuasive”, citing concerns about its unprecedented nature and unverifiability.

  • During the hearing, OpenAI’s lawyers attempted to question Musk about ketamine use during negotiations, citing potential impacts on his decision-making.
  • The judge rejected this, ruling that drug use is irrelevant without concrete evidence of impaired judgment, though she allowed limited discussion of Musk’s attendance at Burning Man, where the Silicon Valley billionaire has interacted with company executives. Musk has said he used ketamine under prescription years ago and denies recent recreational use.

What you should know 

The trial is expected to feature testimony from several high-profile Silicon Valley figures, including Sam Altman, Greg Brockman, Ilya Sutskever, Shivon Zilis, and potentially Microsoft CEO Satya Nadella.

  • Musk is also expected to testify, along with his expert witness on damages. All witnesses are required to enter the courthouse through public entrances, and both parties must cover jury lunches during deliberations.
  • Judge Gonzalez Rogers also indicated that any jury determination on damages would likely be advisory, with the court ultimately deciding the final award.

She further noted that punitive damages are unlikely, narrowing the focus to actual financial claims arising from Musk’s allegations of OpenAI abandoning its nonprofit mission.

Deborah Dan-Awoh

Deborah Dan-Awoh

Deborah Dan-Awoh is a seasoned lifestyle analyst with a knack for storytelling. The focus of her work covers people, money and culture as it relates with business and economy. When she's not keeping tabs on the latest trends in lifestyle and finance- Deborah enjoys networking with industry experts to gain insight into major markets as it affects the populace

Next Post
mergers and acquisition

Executive luxury, shareholder poverty: The problem with corporate cover

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

rabafast

nairametrics




DUNS

Follow us on social media:

  • HOME
  • ABOUT NAIRAMETRICS
  • CONTACT US
  • DISCLAIMER
  • ADs DISCLAIMER
  • COPYRIGHT INFRINGEMENT

© 2026 Nairametrics

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Social Media Auto Publish Powered By : XYZScripts.com
No Result
View All Result
  • Home
  • Exclusives
    • Recapitalization
      • Access Holdings Offer
      • Fidelity Bank Offer
      • GTCO Offer
      • Zenith Bank Offer
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Nairalytics
  • Economy
    • Business News
    • Budget
    • Public Debt
    • Tax
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Public Offer & Right Issues
      • Stock Market News
    • Fixed Income
    • Funds Management
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Market Views
    • Op-Eds
    • Research Analysis
  • Login
  • Sign Up

© 2026 Nairametrics